Minami Toshiyuki 南俊行

… Alternative Names

MINAMI Toshiyuki 南俊行

Less

Researcher Number	00705113
Other IDs
Affiliation (Current)	2025: 兵庫医科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2022 – 2025: 兵庫医科大学, 医学部, 准教授 2018 – 2021: 兵庫医科大学, 医学部, 講師 2016 – 2017: 大阪大学, 医学系研究科, 特任助教(常勤) 2013 – 2015: 大阪大学, 医学(系)研究科(研究院), 助教 2014: 大阪大学, 大学院医学系研究科, 助教
Review Section/Research Field	Principal Investigator Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine Except Principal Investigator Basic Section 52040:Radiological sciences-related / Basic Section 53030:Respiratory medicine-related / Respiratory organ internal medicine
Keywords	Principal Investigator 腫瘍関連マクロファージ / 分子標的治療 / 小細胞肺癌 / 癌免疫療法 / I型インターフェロン / 自然免疫 / 肺癌 / 癌微小環境 / 薬剤性肺障害 / Hippoシグナル伝達系 … More / 薬剤性間質性肺炎 / ドライバー遺伝子変異・転座陽性肺癌 / アスベスト / IL-1受容体 / 癌幹細胞 / インフラマソーム / 悪性胸膜中皮腫 / ADCC / Dasatinib / dasatinib / T-DM1 / trastuzumab / EphA2 / HER2 / 抗癌剤耐性 … More Except Principal Investigator mesothelioma / 放射線生物学 / ピルフェニドン / 放射線防護 / 放射線腫瘍学 / 放射線治療 / 治療効果予測 / SUVmax / FDG集積 / 糖代謝 / 癌の免疫微小環境 / FDG-PET/CT / 予後予測 / 治療効果判定 / 免疫チェックポイント阻害剤 / FDG-PET / 遺伝子改変マウス / signal pathway / BAP1 / トランスジェニックマウス / モデルマウス / 悪性中皮腫 / 内在性リガント / MyD88 / 腫瘍関連線維芽細胞 / 腫瘍関連マクロファージ / 無菌的炎症 / 微小環境 / Toll様受容体 / 化学療法抵抗性 / 無菌的炎症誘導 / アポトーシス小体 / 内在性リガンド / 癌微小環境 / 肺癌 / ＨＥＲ２ / ベバシズマブ / ICAM-1 / ADCC / トラスツズマブ / ラパチニブ / HER2 / 分子標的治療 / 多剤耐性 / 小細胞肺癌 Less

悪性胸膜中皮腫におけるT細胞疲弊を回避する新規がん免疫療法の開発
- Principal Investigator
  
  大搗泰一郎
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University
Pirfenidone as a radioprotectant targeting TGF-beta
- Principal Investigator
  
  土井啓至
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Kindai University
Developing a novel therapeutic strategy to overcome multidrug resistance in small-cell lung cancer by activating innate immunityPrincipal Investigator
- Principal Investigator
  
  南俊行
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University
Treatment response and prognosis prediction of immune checkpoint inhibitors by FDG-PET/CT: A Japanese multicenter prospective study
- Principal Investigator
  
  北島一宏
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  Hyogo Medical University
Overcoming drug-induced interstital lung disease caused by molecular targeted therapy in lung cancerPrincipal Investigator
- Principal Investigator
  
  Minami Toshiyuki
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University
Identification of molecular mechanism underlying malignant mesothelioma development using conditional mouse model and search of therapeutic target molecules
- Principal Investigator
  
  Takashi Kijima
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University
Developing novel therapeutic strategy for the treatment of malignant pleural mesothelioma by targeting asbestos-indeced innate immune inflammationPrincipal Investigator
- Principal Investigator
  
  Minami Toshiyuki
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Hyogo Medical University
Developing novel lung cancer therapy targetting cancer cell intrinsic ligands
- Principal Investigator
  
  Kijima Takashi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Osaka University
Development of novel molecular targeted therapy against small-cell lung cancerPrincipal Investigator
- Principal Investigator
  
  MINAMI TOSHIYUKI
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Osaka University
HER2 target therapy for multidrug-resistant small cell lung cancer
- Principal Investigator
  
  KIJIMA TAKASHI
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Osaka University

All 2023 2022 2020 2019 2018 2016 2015 2013 2012 Other

All Journal Article Presentation

[Journal Article] Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention2023
- Author(s)
  Nakamura Akifumi、Hashimoto Masaki、Kondo Nobuyuki、Matsumoto Seiji、Kuroda Ayumi、Minami Toshiyuki、Kitajima Kazuhiro、Kuribayashi Kozo、Kijima Takashi、Hasegawa Seiki
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 28 Issue: 3 Pages: 409-415
- DOI
  10.1007/s10147-023-02292-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08555
[Journal Article] Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation2023
- Author(s)
  Tada Akio、Minami Toshiyuki、Kitai Hidemi、Higashiguchi Yoko、Tokuda Mayuko、Higashiyama Tomoki、Negi Yoshiki、Horio Daisuke、Nakajima Yasuhiro、Otsuki Taiichiro、Mikami Koji、Takahashi Ryo、Nakamura Akifumi、Kitajima Kazuhiro、Ohmuraya Masaki、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Lung Cancer
  
  Volume: 180 Pages: 107219-107219
- DOI
  10.1016/j.lungcan.2023.107219
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08555
[Journal Article] A superior vena cava aneurysm discovered by chance at regular physical examination2020
- Author(s)
  Nakajima Yasuhiro、Minami Toshiyuki、Ishigaki Hirotoshi、Sakai Eirou、Takahashi Ryo、Yokoi Takashi、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Respiratory Investigation
  
  Volume: - Issue: 4 Pages: 291-294
- DOI
  10.1016/j.resinv.2019.12.002
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K15962
[Journal Article] Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma2020
- Author(s)
  Horio Daisuke、Minami Toshiyuki、Kitai Hidemi、Ishigaki Hirotoshi、Higashiguchi Yoko、Kondo Nobuyuki、Hirota Seiichi、Kitajima Kazuhiro、Nakajima Yasuhiro、Koda Yuichi、Fujimoto Eriko、Negi Yoshiki、Niki Maiko、Kanemura Shingo、Shibata Eisuke、Mikami Koji、Takahashi Ryo、Yokoi Takashi、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Cancer Science
  
  Volume: - Issue: 8 Pages: 2895-2906
- DOI
  10.1111/cas.14523
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15962, KAKENHI-PROJECT-19K17653, KAKENHI-PROJECT-19K17654
[Journal Article] Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment.2020
- Author(s)
  Yoshikawa Y, Kuribayashi K, Minami T, Ohmuraya M, Kijima T.
- Journal Title
  
  Front Oncol.
  
  Volume: 10 Pages: 554570-554570
- DOI
  10.3389/fonc.2020.554570
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08405, KAKENHI-PROJECT-18K07212, KAKENHI-PROJECT-18K08161
[Journal Article] Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma - Comparison with contrast-enhanced CT.2019
- Author(s)
  Kitajima K, Hashimoto M, Katsuura T, Kondo N, Minami T, Kuribayashi K, Hasegawa S, Kijima T, Yamakado K.
- Journal Title
  
  Oncotarget.
  
  Volume: 10(63) Issue: 63 Pages: 6816-6828
- DOI
  10.18632/oncotarget.27324
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08161
[Journal Article] Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression2019
- Author(s)
  Wettersten Hiromi I.、Weis Sara M.、Pathria Paulina、Von Schalscha Tami、Minami Toshiyuki、Varner Judith A.、Cheresh David A.
- Journal Title
  
  Cancer Research
  
  Volume: 79 Issue: 19 Pages: 5048-5059
- DOI
  10.1158/0008-5472.can-19-1246
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15962
[Journal Article] EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest2019
- Author(s)
  Ishigaki Hirotoshi、Minami Toshiyuki、Morimura Osamu、Kitai Hidemi、Horio Daisuke、Koda Yuichi、Fujimoto Eriko、Negi Yoshiki、Nakajima Yasuhiro、Niki Maiko、Kanemura Shingo、Shibata Eisuke、Mikami Koji、Takahashi Ryo、Yokoi Takashi、Kuribayashi Kozo、Kijima Takashi
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 519 Issue: 4 Pages: 846-853
- DOI
  10.1016/j.bbrc.2019.09.076
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K17653, KAKENHI-PROJECT-18K15962, KAKENHI-PROJECT-18K15963
[Journal Article] Challenges for the development of immunotherapy in small-cell lung cancer.2018
- Author(s)
  Minami T, Kinehara Y, Morimura O, Kitai H, Fujimoto E, Negi Y, Kanemura S, Shibata E, Mikami K, Yokoi T, Kuribayashi K, Kijima T.
- Journal Title
  
  Med Res Arch.
  
  Volume: 6 Pages: 1-15
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K15962
[Journal Article] Weight Loss Associated with Platinum-Based Chemotherapy in Patients with Advanced Lung Cancer2016
- Author(s)
  Kayoko Morio, Toshiyuki Minami, Takashi Sozu, Kazuyuki Niki, Takashi Kijima, Etsuko Uejima
- Journal Title
  
  Chemotherapy
  
  Volume: 61 Issue: 5 Pages: 256-261
- DOI
  10.1159/000443983
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26860606
[Journal Article] Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.2015
- Author(s)
  Kinehara Y, Minami T, Kijima T, Hoshino S, Morimura O, Otsuka T, Hayama Y, Fukushima K, Takeuchi Y, Higashiguchi M, Miyake K, Hirata H, Nagatomo I, Inoue K, Takeda Y, Kida H, Kumanogoh A.
- Journal Title
  
  Lung Cancer.
  
  Volume: 87 Issue: 3 Pages: 321-325
- DOI
  10.1016/j.lungcan.2015.01.003
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24591165, KAKENHI-PROJECT-26860606
[Journal Article] Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.2013
- Author(s)
  Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, Takahashi R, Miyake K, Higashiguchi M, Morimura O, Ihara S, Tsujino K, Hirata H, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A.
- Journal Title
  
  Scientific Reports
  
  Volume: 3 Issue: 1 Pages: 2669-2669
- DOI
  10.1038/srep02669
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591165, KAKENHI-PUBLICLY-25133705, KAKENHI-PROJECT-25670143
[Journal Article] HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer.2012
- Author(s)
  Minami T, Kijima T, Otani Y, Kohmo S, Takahashi R, Nagatomo I, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 11(4) Issue: 4 Pages: 830-841
- DOI
  10.1158/1535-7163.mct-11-0884
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] 腫瘍関連マクロファージの制御を介した悪性胸膜中皮腫に対する抗PD-1抗体と血管新生阻害薬併用療法の抗腫瘍効果2023
- Author(s)
  多田陽郎、南　俊行、北井秀美、東口洋子、村上美沙、河村直樹、藤岡　毅、近藤孝憲、森下実咲、徳田麻佑子、東山友樹、祢木芳樹、堀尾大介、大搗泰一郎、三上浩司、高橋　良、栗林康造、木島貴志
- Organizer
  第63 回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-20K08555
[Presentation] 悪性胸膜中皮腫に対する抗PD-1抗体と血管新生阻害薬併用療法の抗腫瘍効果について2022
- Author(s)
  多田陽郎、南　俊行、森下美咲、徳田麻佑子、村上美沙、神取恭史、河村直樹、近藤孝憲、清田穣太郎、西村　駿、長野昭近、東山友樹、祢木芳樹、堀尾大介、大搗泰一郎、三上浩司、高橋　良、北島一宏、栗林康造、木島貴志
- Organizer
  第3回日本石綿・中皮腫学会学術集会
- Data Source
  KAKENHI-PROJECT-20K08555
[Presentation] 悪性胸膜中皮腫（Malignant Pleural Mesothelioma: MPM）微小環境中の腫瘍関連マクロファージにおけるインフラマソームの役割2019
- Author(s)
  堀尾大介、南　俊行、幸田裕一、袮木芳樹、二木麻衣子、柴田英輔、三上浩司、高橋　良、横井　崇、栗林康造、木島貴志
- Organizer
  第59回　日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-18K15962
[Presentation] 悪性胸膜中皮腫（Malignant Pleural Mesothelioma: MPM）微小環境中の腫瘍関連マクロファージにおけるインフラマソームの役割2019
- Author(s)
  堀尾大介、南　俊行、幸田裕一、藤本英利子、祢木芳樹、金村晋吾、柴田英輔、三上浩司、高橋　良、横井　崇、栗林康造、木島貴志
- Organizer
  第59回日本呼吸器学会学術講演会
- Data Source
  KAKENHI-PROJECT-18K15962
[Presentation] 微小環境中の腫瘍関連マクロファージにおけるインフラマソームが悪性胸膜中皮腫の進展に及ぼす役割2019
- Author(s)
  堀尾大介、南　俊行、幸田裕一、袮木芳樹、二木麻衣子、柴田英輔、三上浩司、高橋　良、横井　崇、北島一宏、栗林康造、木島貴志
- Organizer
  第1回　日本石綿・中皮腫学会
- Data Source
  KAKENHI-PROJECT-18K15962
[Presentation] 悪性胸膜中皮腫における腫瘍関連マクロファージのインフラマソームの役割2018
- Author(s)
  堀尾大介、南　俊行、幸田裕一、藤本英利子、祢木芳樹、金村晋吾、柴田英輔、三上浩司、高橋　良、横井　崇、栗林康造、木島貴志1
- Organizer
  第25回石綿・中皮腫研究会
- Data Source
  KAKENHI-PROJECT-18K15962
[Presentation] トラスツズマブ-エムタンシン（T-DM1）は抗癌剤およびトラスツズマブ耐性HER2陽性小細胞肺癌の増殖を抑制する2016
- Author(s)
  森村　治、木島貴志、南　俊行、小山正平、甲原雄平、長　彰翁、大塚倫之、熊ノ郷　淳
- Organizer
  第56回日本呼吸器学会
- Place of Presentation
  国立京都国際会館（京都府・京都市）
- Year and Date
  2016-04-08
- Data Source
  KAKENHI-PROJECT-26860606
[Presentation] 分子標的治療による小細胞肺癌の抗癌剤耐性の克服2013
- Author(s)
  南　俊行、木島貴志、大谷安司
- Organizer
  第17回日本がん分子標的治療学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] Molecular targeting therapy to overcome chemoresistance in small cell lung cancer2012
- Author(s)
  南俊行，木島貴志，河面聡，大谷安司，高橋良，長友泉，武田吉人，立花功，熊ノ郷淳
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  北海道札幌
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer2012
- Author(s)
  南俊行，木島貴志，大谷安司，河面聡，高橋良，長友泉，平田陽彦，鈴木真優美，井上幸治，武田吉人，木田博，立花功，熊ノ郷淳
- Organizer
  第103回　AACR (Ammerican Association for Cancer Research) annual meeting
- Place of Presentation
  米国シカゴ
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] HER2陽性再発小細胞肺癌に対するirinotecan + trastuzumab併用療法（基礎研究から臨床応用まで）
- Author(s)
  南俊行，甲原雄平，木島貴志，森村治、大塚倫之，三宅浩太郎，竹内美子、井上幸治，長友泉，木田博，熊ノ郷淳
- Organizer
  第55回日本肺癌学会学術集会
- Place of Presentation
  京都
- Year and Date
  2014-11-14 – 2014-11-16
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] EphA2レセプター阻害はセネッセンス誘導を介して小細胞肺がん細胞の増殖を抑制する
- Author(s)
  森村治，木島貴志，南俊行，熊ノ郷淳
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] Targeting HER2 and VEGF stepwise can overcome multidrug resistance in small cell lung cancer.
- Author(s)
  Minami T, Kijima T, Kinehara Y, Morimura O, Higashiguchi M, Miyake K, Hirata H, Takeuchi Y, Fukushima K, Hayama Y, Inoue K, Nagatomo I, Takeda Y, Kida H, Kumanogoh A.
- Organizer
  第105回米国癌学会(AACR) 2014
- Place of Presentation
  San Diego、CA, USA
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] EphA2 receptor inhibition suppresses proliferation of small cell lung cancer (SCLC) cells via cell senescenece.
- Author(s)
  森村治、南俊行、木島貴志、武田吉人、長友泉、熊ノ郷淳
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26860606
[Presentation] Trastuzumab-based chemotherapy for HER2-positive refractory relapsed small-cell lung cancer (from bench to bed side)
- Author(s)
  甲原雄平，南俊行，木島貴志，福島清春，葉山善友，竹内美子，平田陽彦，井上幸治，熊ノ郷淳
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-24591165
[Presentation] HER2陽性再発小細胞肺癌に対するirinotecan + trastuzumab併用療法（基礎研究から臨床応用まで）
- Author(s)
  南　俊行、甲原雄平、木島貴志、星野茂則、森村　治、東口将佳、三宅浩太郎、竹内美子、葉山善友、福島清春、長　彰翁、石島里佳子、仲谷健史、松木隆典、大塚倫之、平田陽彦、井上幸治、長友　泉、武田吉人、木田　博、熊ノ郷　淳1
- Organizer
  第55回日本肺癌学会学術集会
- Place of Presentation
  京都
- Year and Date
  2014-11-14 – 2014-11-16
- Data Source
  KAKENHI-PROJECT-26860606
[Presentation] Trastuzumab-based Chemotherapy for HER2-positive Refractory Relapsed Small-Cell Lung Cancer (from Bench to Bed Side)
- Author(s)
  甲原雄平、南　俊行、木島貴志，福島清春，葉山善友，竹内美子，平田陽彦，井上幸治，熊ノ郷淳
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Year and Date
  2014-07-17 – 2014-07-19
- Data Source
  KAKENHI-PROJECT-26860606
[Presentation] Targeting stepwise HER2 and VEGF can overcome multidrug resistance in small cell lung cancer
- Author(s)
  Toshiyuki Minami, Takashi Kijima, Osamu Morimura, Yuhei Kinehara, Masayoshi Higashiguchi, Kotaro Miyake, Haruhiko Hirata, Yoshiko Takeuchi, Kiyoharu Fukushima, Yoshitomo Hayama, Koji Inoue, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Atsushi Kumanogoh
- Organizer
  AACR (American Association for Cancer Research) 105th Annual Meeting
- Place of Presentation
  San Diego, CA, USA
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-26860606

1. KIJIMA TAKASHI (90372614)

# of Collaborated Projects: 7 results

# of Collaborated Products: 15 results
2. MORIMURA OSAMU (80743765)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
3. 北島一宏 (80448860)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. NAGATOMO Izumi (10570583)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
5. KOHMO Satoshi (40625670)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
6. 小山正平 (80767559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 長彰翁 (20751390)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 内藤祐二朗 (30800982)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 吉川良恵 (10566673)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 大村谷昌樹 (60398229)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 山門亨一郎 (20263022)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 甲斐田勇人 (40299425)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 大崎洋充 (90392349)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 渡部直史 (90648932)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 高濱隆幸 (90716359)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 武田吉人 (40452388)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 土井啓至 (50529047)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. 立野沙織 (50881463)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
19. 大搗泰一郎 (30594767)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 三上浩司

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Minami Toshiyuki 南 俊行

MINAMI Toshiyuki 南 俊行

Research Projects

Research Products

Co-Researchers

悪性胸膜中皮腫におけるT細胞疲弊を回避する新規がん免疫療法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pirfenidone as a radioprotectant targeting TGF-beta

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Developing a novel therapeutic strategy to overcome multidrug resistance in small-cell lung cancer by activating innate immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Treatment response and prognosis prediction of immune checkpoint inhibitors by FDG-PET/CT: A Japanese multicenter prospective study

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Overcoming drug-induced interstital lung disease caused by molecular targeted therapy in lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of molecular mechanism underlying malignant mesothelioma development using conditional mouse model and search of therapeutic target molecules

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Developing novel therapeutic strategy for the treatment of malignant pleural mesothelioma by targeting asbestos-indeced innate immune inflammationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Developing novel lung cancer therapy targetting cancer cell intrinsic ligands

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel molecular targeted therapy against small-cell lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

HER2 target therapy for multidrug-resistant small cell lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A superior vena cava aneurysm discovered by chance at regular physical examination2020

Author(s)

Journal Title

DOI

Data Source

Minami Toshiyuki 南俊行

MINAMI Toshiyuki 南俊行